Clinical Scorecard: AI and Diabetes: Promise and Precaution

At a Glance

Key Highlights

• AI tools improve glycemic control and reduce patient burden.
• Potential for early identification of diabetes risk using AI and biomarkers.
• Call for coordinated global action for real-world implementation of AI in diabetes care.
• Concerns over privacy, autonomy, and over-reliance on automated decision-making.
• Need for education in AI literacy and ethics among diabetes professionals.

Guideline-Based Recommendations

Diagnosis

• Utilize AI systems for early and accurate identification of diabetes risk.

Management

• Implement AI tools as medical interventions with appropriate regulatory standards.

Monitoring & Follow-up

• Ensure AI systems are monitored for long-term effects and ethical considerations.

Risks

• Address potential over-reliance on AI and the implications for patient autonomy.

Patient & Prescribing Data

Patients with diabetes and those at risk for diabetes.

AI can enhance treatment personalization and intervention strategies.

Clinical Best Practices

• Adopt a 'human-in-the-loop' approach to maintain clinician responsibility.
• Encourage privacy-preserving methods like federated learning.
• Focus on equity to ensure AI tools are accessible to all patients.

References

• The Lancet Diabetes & Endocrinology